SPY363.22+5.76 1.61%
DIA300.43+4.54 1.53%
IXIC12,036.79+156.15 1.31%

Aytu BioScience Q1 EPS $(0.04) Beats $(0.05) Estimate, Sales $13.50M Beat $13.33M Estimate

Aytu BioScience (NASDAQ:AYTU) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20 percent. This is a 87.5 percent increase over losses of $(0.32) per share from the

· 11/12/2020 16:03
Aytu BioScience (NASDAQ:AYTU) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20 percent. This is a 87.5 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $13.50 million which beat the analyst consensus estimate of $13.33 million by 1.28 percent. This is a 837.50 percent increase over sales of $1.44 million the same period last year.